The DEA Just Registered 900 Dispensaries. Nobody Registered a Plan for the Patient.

On Friday, October 30, Attorney General Todd Blanche announced that the DEA had issued federal registrations to more than 900 medical marijuana dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia, and West Virginia. The Justice Department called it the “first phase” of putting rescheduling into practice. Nearly 7,000 medical cannabis businesses have applied.

Washington registered the shelves. Nobody has registered a plan for the patient.

Read the Justice Department’s own announcement and the obligations it lists are about the building: security, recordkeeping, inventory. “The American people deserve access to the best medical treatments in the world,” Blanche said. That is a sentence about access. What it leaves out is what happens after the sale: who asks how much the patient is using, whether it is helping, whether the pain or the sleep or the anxiety is getting better or whether the jar is just getting emptier faster.

The gate to name before anyone calls this a change on the ground: it covers products sold under a state medical license, in the seven states above, to businesses that applied and were approved. The department says plainly that “state licensure alone does not automatically grant federal registration.” It is not adult-use legalization, and it does not make cannabis a prescription. No federal order has told a doctor how to dose it.

The same day showed how narrow the door is. The DEA refused registration to a Minneapolis dispensary, In-Dispensary, because Minnesota licenses shops to sell both medical and non-medical cannabis, which the agency says falls outside the federal definition of a state medical license. The order to show cause, signed by Cheri Oz of the DEA’s Diversion Control Division, cites weak safeguards against diversion in Minnesota and notes that veterans can get medical cannabis with an ID and a self-attestation of a qualifying condition, with no doctor’s certification. Minnesota’s Office of Cannabis Management says the order does not affect state law. The shop can request a hearing within 30 days. A separate hearing on broader rescheduling has finished its testimony, with no outcome reported.

Notice what the DEA objected to: a missing doctor. The agency is, in effect, arguing for more clinical contact than Minnesota’s veterans pathway requires. That is the one place in this story where a clinician appears at all.

This week, for providers: ask your medical director whether your program’s cannabis policy has been reviewed since April, when the DOJ order moved state-licensed medical products to Schedule III. Policies written for Schedule I may read strangely now, and your clients are already asking.

If you hold a medical card, none of this changes the fact that you are the only one in the room tracking whether it is working for you. That job is still yours, and it was never a federal one.